Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010747
Filing Date
2015-11-16
Accepted
2015-11-13 21:46:43
Documents
14
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne-10q_20150930.htm 10-Q 1389697
2 EX-10.1 srne-ex101_150.htm EX-10.1 696248
3 EX-10.2 srne-ex102_151.htm EX-10.2 747744
4 EX-10.3 srne-ex103_152.htm EX-10.3 109610
5 EX-10.4 srne-ex104_319.htm EX-10.4 318449
6 EX-31.1 srne-ex311_8.htm EX-31.1 9657
7 EX-31.2 srne-ex312_6.htm EX-31.2 9578
8 EX-32.1 srne-ex321_10.htm EX-32.1 10946
  Complete submission text file 0001564590-15-010747.txt   7553933

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT srne-20150930.xml EX-101.INS 931997
10 XBRL TAXONOMY EXTENSION SCHEMA srne-20150930.xsd EX-101.SCH 58365
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20150930_cal.xml EX-101.CAL 62456
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20150930_def.xml EX-101.DEF 222660
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20150930_lab.xml EX-101.LAB 433757
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20150930_pre.xml EX-101.PRE 348945
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 151230818
SIC: 8731 Services-Commercial Physical & Biological Research